Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Cash & Equivalents (2016 - 2022)

Historic Cash & Equivalents for Inogen (INGN) over the last 11 years, with Q3 2022 value amounting to $209.6 million.

  • Inogen's Cash & Equivalents fell 1322.28% to $209.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $209.6 million, marking a year-over-year decrease of 1322.28%. This contributed to the annual value of $235.5 million for FY2021, which is 1111.61% up from last year.
  • As of Q3 2022, Inogen's Cash & Equivalents stood at $209.6 million, which was down 1322.28% from $223.6 million recorded in Q2 2022.
  • Over the past 5 years, Inogen's Cash & Equivalents peaked at $241.6 million during Q3 2021, and registered a low of $154.3 million during Q1 2018.
  • For the 5-year period, Inogen's Cash & Equivalents averaged around $204.4 million, with its median value being $212.0 million (2020).
  • As far as peak fluctuations go, Inogen's Cash & Equivalents skyrocketed by 4679.04% in 2018, and later tumbled by 1322.28% in 2022.
  • Inogen's Cash & Equivalents (Quarter) stood at $196.6 million in 2018, then grew by 0.71% to $198.0 million in 2019, then increased by 7.03% to $212.0 million in 2020, then rose by 11.12% to $235.5 million in 2021, then fell by 10.99% to $209.6 million in 2022.
  • Its Cash & Equivalents stands at $209.6 million for Q3 2022, versus $223.6 million for Q2 2022 and $213.4 million for Q1 2022.